首页> Translational lung cancer research> Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target.

Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target.

导出 LinkOut

翻译打印收藏纠错

第一作者： Danish,Safi

第一单位： Division of General Internal Medicine, Department of Internal Medicine, University of Iowa, IA, USA.

作者： Danish,Safi ^[1] ; Taher,Abu Hejleh ^[2] ; Muhammad,Furqan ^[2]

作者单位： Division of General Internal Medicine, Department of Internal Medicine, University of Iowa, IA, USA. ^[1] Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, IA, USA. ^[2]

关键词 METexon14 skipping Mesenchymal-epithelial transition (MET)non-small cell lung cancer (NSCLC)

DOI 10.21037/tlcr-20-588

PMID 33569327

发布时间 2021-02-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Translational lung cancer research

2021年10卷1期

462-474页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Translational lung cancer research

2021年10卷1期

462-474页

检索历史清除

Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target.

Translational lung cancer research

相似文献

同项目论文

Translational lung cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Narrative review: mesenchymal-epithelial transition inhibitors-meeting their target.

Translational lung cancer research

相似文献

同项目论文

Translational lung cancer research

相关期刊

检索历史清除